AU7449000A - Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody - Google Patents
Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibodyInfo
- Publication number
- AU7449000A AU7449000A AU74490/00A AU7449000A AU7449000A AU 7449000 A AU7449000 A AU 7449000A AU 74490/00 A AU74490/00 A AU 74490/00A AU 7449000 A AU7449000 A AU 7449000A AU 7449000 A AU7449000 A AU 7449000A
- Authority
- AU
- Australia
- Prior art keywords
- antibody
- derivative
- human type
- transplanted
- determining domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
- C07K16/3084—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27829099 | 1999-09-30 | ||
JP11/278290 | 1999-09-30 | ||
PCT/JP2000/006773 WO2001023573A1 (en) | 1999-09-30 | 2000-09-29 | Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7449000A true AU7449000A (en) | 2001-04-30 |
Family
ID=17595301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74490/00A Abandoned AU7449000A (en) | 1999-09-30 | 2000-09-29 | Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7449000A (en) |
WO (1) | WO2001023573A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1272205B1 (en) * | 2000-03-07 | 2013-08-07 | The Johns Hopkins University | Sialoadhesin factor-2 antibodies |
PT1572748E (en) * | 2002-12-17 | 2010-09-28 | Merck Patent Gmbh | Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
WO2005053742A1 (en) * | 2003-12-04 | 2005-06-16 | Kyowa Hakko Kogyo Co., Ltd. | Medicine containing antibody composition |
GB201403972D0 (en) * | 2014-03-06 | 2014-04-23 | Ucl Business Plc | Chimeric antigen receptor |
WO2024040195A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997034634A1 (en) * | 1996-03-20 | 1997-09-25 | Sloan-Kettering Institute For Cancer Research | Single chain fv constructs of anti-ganglioside gd2 antibodies |
-
2000
- 2000-09-29 AU AU74490/00A patent/AU7449000A/en not_active Abandoned
- 2000-09-29 WO PCT/JP2000/006773 patent/WO2001023573A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001023573A1 (en) | 2001-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
AU2001259215A1 (en) | Human anti-cd40 antibodies and methods of making and using same | |
AU3030995A (en) | Absorbent structure of sanitary article | |
AU4640400A (en) | Analysis of differential protein expression | |
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
AU4670800A (en) | Novel compositions comprising trimetrexate and methods of their synthesis and use | |
AU3068699A (en) | Skin equivalent and methods of forming and using same | |
AU7100200A (en) | Bleached grain and grain products and methods of preparation | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
AU7676300A (en) | Human anti-adipocyte monoclonal antibodies and their use | |
AU7358800A (en) | Compositions and methods for modification of skin lipid content | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
AU4848200A (en) | Intravascular device and methods of manufacture and use | |
AU5269198A (en) | Preparation of concealed taste preparations of antibacterially active quinolone derivatives | |
AU5674596A (en) | Inhibitors of bacterial sialidase and methods of making and using the same | |
AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
AU5759000A (en) | Cold-plasma deposition treatment of seeds and other living matter | |
AU7449000A (en) | Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody | |
AU1911301A (en) | Novel bacterial isolate and the preparation and use of its active metabolites | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
AU3501700A (en) | Human endokine alpha and methods of use | |
AU1812601A (en) | Cover member and method of making same | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU2738000A (en) | Oral hygiene preparations; associated methods and kit | |
AU6777596A (en) | Treatment of human prostate disease with beta-lapachone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |